Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater

2020 ◽  
Vol 26 (1) ◽  
pp. 78-86
Author(s):  
Takayuki Jodai ◽  
Koichi Saruwatari ◽  
Tokunori Ikeda ◽  
Eiji Moriyama ◽  
Kosuke Kashiwabara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Cancer Patients ◽  
Predictive Value ◽  
Performance Status ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Programmed Cell Death 1

scholarly journals Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

2020 ◽  
Vol 11 (9) ◽  
pp. 2465-2472
Author(s):  
Takehiro Tozuka ◽  
Satoru Kitazono ◽  
Hiroaki Sakamoto ◽  
Hiroshi Yoshida ◽  
Yoshiaki Amino ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Brain Metastases ◽  
Cancer Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Programmed Cell Death 1 ◽  
Poor Efficacy
Sign in / Sign up

Export Citation Format

Share Document